Biopharmaceutical
Biotechnology
Cancer Prevention

Geron

31,706

$1.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (+2.78%) Today
+$0.02 (+1.80%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Geron and other stocks, options, ETFs, and crypto commission-free!

About GERN

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Read More The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.

CEO
John A. Scarlett
Employees
46
Headquarters
Menlo Park, California
Founded
1990
Market Cap
222.38M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.52M
High Today
$1.12
Low Today
$1.04
Open Price
$1.10
Volume
1.62M
52 Week High
$2.14
52 Week Low
$0.75

Collections

Biopharmaceutical
Biotechnology
Cancer Prevention
Pharmaceutical
Health
Medical
Technology

GERN News

ReutersApr 4

Edited Transcript of GERN earnings conference call or presentation 12-Mar-20 8:30pm GMT

Q4 2019 Geron Corp Earnings Call MENLO PARK Apr 4, 2020 (Thomson StreetEvents) -- Edited Transcript of Geron Corp earnings conference call or presentation Thur
137

GERN Earnings

-$0.20
-$0.13
-$0.07
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected Apr 30, After Hours

People Also Bought

Novavax

40,626

$17.22

+0.23%

Novavax

40,626

$17.22

+0.23%

Oragenics

53,160

$0.7597

+21.59%

India Globalization Capital

60,876

$0.43

-6.07%

New Age Beverages

59,391

$1.18

-2.48%

You May Also Like

CTAA
XLB
BAH
ETJ
LMPX
VG
RILYI
AX
ICF
AGO
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy GERN

Market Price$1.13
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Geron stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up